welcome to DuchenneXchange
- a positively charged Duchenne muscular dystrophy community.- join today!
- log in
Inside “Custom Cars” For Gene Delivery
source: Get Science
year: 2018
summary/abstract:Gene therapy shows great promise to be potentially transformational treatments for a number of single-gene disorders, such as Duchenne muscular dystrophy, hemophilia and cystic fibrosis.
Gene therapy uses an engineered vector to deliver a replacement copy of a gene to diseased cells. In the case of single-gene disorders, introducing a working gene can help restore function of a faulty or missing protein.
While it’s a straightforward concept, it can be difficult to execute. Successful vectors must be able to carry the gene, which sometimes can be very large; target the right type of cell for a specific disease; insert the new genetic material into the cell; and “activate” the gene to create the missing protein. Scientists also need to engineer vectors to avoid an immune response that could influence how well the therapy works.
full text sourcerareRelated
-
Sarepta Announces Clinical Hold Lifted for its Duchenne Muscular Dystrophy Micro-dystrophin Gene Therapy ProgramSarepta Therapeutics, Inc., a commercial...
-
CHMP opposes approval of Exondys 51 to treat DMD in EuropeThe Committee for Medicinal Products for...
-
The emerging role of viral vectors as vehicles for DMD gene editingDuchenne muscular dystrophy (DMD) is a g...
-
Hope in Translation: Bringing Gene Therapy to the ClinicIn 1987, scientists first uncovered the ...
-
Sarepta shoots higher as sales of $300,000-a-year drug exceed expectationsSarepta announced second-quarter revenue...
-
FDA and NIH to loosen oversight of gene therapy developmentCiting the need to safely expedite the d...
-
DMD Gene Therapy Clinical Trial: Making a Difference by Gene Replacement (Dr. Jerry Mendell)https://www.youtube.com/watch?v=AeTqv29h...